Bicycle Therapeutics plc (NASDAQ:BCYC) Receives $29.14 Consensus PT from Brokerages
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year price […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year price […]
